Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute leukemia in adults

M Crump1, A Keating

  • 1Toronto Hospital, Toronto, Ontario, Canada.

Current Opinion in Hematology
|July 1, 1995
PubMed
Summary
This summary is machine-generated.

Molecular oncology advances offer new insights into leukemia, improving prognosis and treatment response. Despite progress, new strategies are needed, especially for elderly patients with acute myeloid and lymphoblastic leukemia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First-line therapy, autologous stem-cell transplantation, and post-transplantation maintenance in the management of newly diagnosed mantle cell lymphoma.

Current oncology (Toronto, Ont.)·2020
Same author

Low-threshold SARS-CoV-2 testing facility for hospital staff: Prevention of COVID-19 outbreaks?

International journal of hygiene and environmental health·2020
Same author

Treatment outcomes for older patients with relapsed/refractory aggressive lymphoma receiving salvage chemotherapy and autologous stem cell transplantation are similar to younger patients: a subgroup analysis from the phase III CCTG LY.12 trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same author

Management of Early-stage Hodgkin Lymphoma: A Practice Guideline.

Clinical oncology (Royal College of Radiologists (Great Britain))·2016
Same author

T-Cell Blast Crisis in Chronic Myeloid Leukemia.

Leukemia & lymphoma·2016
Same author

Highlights of the Fifth International Symposium on Autologous Bone Marrow Transplantation Omaha, Nebraska, August 23-25, 1990.

Leukemia & lymphoma·2016
Same journal

Dynamic myeloid suppressor states in cancer and inflammation and their therapeutic potential.

Current opinion in hematology·2026
Same journal

Factor XIa inhibition for the prevention of thrombosis: mechanism, clinical trial signals, and indication-specific positioning.

Current opinion in hematology·2026
Same journal

Nutrition as a regulator of hematopoietic stem cell biology and transplantation.

Current opinion in hematology·2026
Same journal

From biomimicry to clinical actionability: rethinking high-shear thrombosis as a mechanobiological system.

Current opinion in hematology·2026
Same journal

Bidirectional relationship between metabolic and thrombotic disease mechanisms.

Current opinion in hematology·2026
Same journal

The dual role of the brain-derived neurotrophic factor as a regulator of hemostasis and thrombotic risk.

Current opinion in hematology·2026
See all related articles

Area of Science:

  • Molecular oncology
  • Hematology
  • Cancer genetics

Background:

  • Recent molecular oncology discoveries illuminate acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) pathogenesis.
  • Cytogenetic abnormalities and gene mutations/expression provide prognostic information for guiding therapy.
  • Understanding disease mechanisms is crucial for effective treatment strategies.

Purpose of the Study:

  • To review current insights into leukemia pathogenesis and natural history.
  • To highlight the prognostic value of molecular markers in AML and ALL.
  • To assess recent therapeutic advancements and identify future research needs.

Main Methods:

  • Review of recent literature on molecular oncology in leukemia.
  • Analysis of data from randomized trials on postremission chemotherapy.

Related Experiment Videos

  • Evaluation of treatment outcomes in elderly leukemia patients.

    • Main Results:

    • Molecular markers significantly enhance prognostic accuracy and treatment prediction.
    • Intensive postremission chemotherapy, including high-dose cytarabine and stem cell transplantation, improves leukemia-free survival.
    • Treatment progress in elderly leukemia patients remains modest.

    Conclusions:

    • Molecular insights are transforming AML and ALL management.
    • Established intensive therapies show efficacy, but novel strategies are essential.
    • Further research is required for improved outcomes, particularly in the elderly population.